Hans Alkemade

678 total citations
21 papers, 545 citations indexed

About

Hans Alkemade is a scholar working on Dermatology, Cell Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Hans Alkemade has authored 21 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Dermatology, 6 papers in Cell Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Hans Alkemade's work include Autoimmune Bullous Skin Diseases (5 papers), Nonmelanoma Skin Cancer Studies (5 papers) and melanin and skin pigmentation (4 papers). Hans Alkemade is often cited by papers focused on Autoimmune Bullous Skin Diseases (5 papers), Nonmelanoma Skin Cancer Studies (5 papers) and melanin and skin pigmentation (4 papers). Hans Alkemade collaborates with scholars based in Netherlands, United States and Sweden. Hans Alkemade's co-authors include Joost Schalkwijk, Patrick L.J.M. Zeeuwen, H.O.F. Molhuizen, P.C.M. van de Kerkhof, B. Wieringa, G. J. de Jongh, P.E.J. van Erp, Rolph Pfundt, P. H. K. Jap and Huib J. E. Croes and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Investigative Dermatology.

In The Last Decade

Hans Alkemade

18 papers receiving 521 citations

Peers

Hans Alkemade
G. J. de Jongh Netherlands
Michael Plotnick United States
Gys J. de Jongh Netherlands
Soo‐Il Chung South Korea
E. Proksch Germany
Melanie K. Kuechle United States
G. J. de Jongh Netherlands
Hans Alkemade
Citations per year, relative to Hans Alkemade Hans Alkemade (= 1×) peers G. J. de Jongh

Countries citing papers authored by Hans Alkemade

Since Specialization
Citations

This map shows the geographic impact of Hans Alkemade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Alkemade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Alkemade more than expected).

Fields of papers citing papers by Hans Alkemade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Alkemade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Alkemade. The network helps show where Hans Alkemade may publish in the future.

Co-authorship network of co-authors of Hans Alkemade

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Alkemade. A scholar is included among the top collaborators of Hans Alkemade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Alkemade. Hans Alkemade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alkemade, Hans, et al.. (2023). Translation and Validation of the Dutch Version of the Sun Exposure and Protection Index. Dermatology. 240(2). 282–290. 2 indexed citations
2.
Peppelman, Malou, Marianne B. Crijns, Hans Alkemade, et al.. (2020). Biopsy outperforms reflectance confocal microscopy in diagnosing and subtyping basal cell carcinoma: results and experiences from a randomized controlled multicentre trial*. British Journal of Dermatology. 184(4). 663–671. 16 indexed citations
3.
Alkemade, Hans, et al.. (2020). Huidkankerzorg verbetert door gerichte training van huisartsen. Huisarts en Wetenschap. 64(1). 23–25.
4.
Peppelman, Malou, Hans Alkemade, Jan C.M. Hendriks, et al.. (2016). Diagnosis of Basal Cell Carcinoma by Reflectance Confocal Microscopy: Study Design and Protocol of a Randomized Controlled Multicenter Trial. JMIR Research Protocols. 5(2). e114–e114. 6 indexed citations
5.
Grutters, Janneke P.C., Hans Alkemade, Remco van Doorn, et al.. (2015). Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study. Acta Dermato Venereologica. 96(3). 346–350. 3 indexed citations
6.
Valk, P.G.M. van der, C.R.L. Boot, Andrea W.M. Evers, et al.. (2013). A simple tool with which to study the course of chronic hand eczema in clinical practice: a reduced‐item score. Contact Dermatitis. 69(2). 112–117. 12 indexed citations
7.
Aben, Katja K.H., et al.. (2009). No Increased Risk of Cancer after Coal Tar Treatment in Patients with Psoriasis or Eczema. Journal of Investigative Dermatology. 130(4). 953–961. 56 indexed citations
8.
Vissers, W.H.P.M., et al.. (2007). Middle-aged man presenting with erythematous brownish plaques. Clinical and Experimental Dermatology. 32(5). 617–618.
9.
Kerkhof, P.C.M. van de, Marloes M. Kleinpenning, E.M.G.J. de Jong, et al.. (2006). Current and future treatment options for acne. Journal of Dermatological Treatment. 17(4). 198–204. 16 indexed citations
10.
Alkemade, Hans & L Juhlin. (2000). Unilateral lentiginosis with nevus depigmentosus on the other side. Journal of the American Academy of Dermatology. 43(2). 361–363. 8 indexed citations
11.
Alkemade, Hans & L Juhlin. (2000). Unilateral lentiginosis with nevus depigmentosus on the other side. Journal of the American Academy of Dermatology. 43(2). 361–363. 4 indexed citations
12.
Kuijpers, A.L.A., Patrick L.J.M. Zeeuwen, Gijs J. De Jongh, et al.. (1996). Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?. Archives of Dermatological Research. 288(11). 641–647. 3 indexed citations
13.
Zeeuwen, Patrick L.J.M., et al.. (1996). Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?. Archives of Dermatological Research. 288(11). 641–647. 18 indexed citations
14.
Pfundt, Rolph, Fred van Ruissen, Hans Alkemade, et al.. (1996). Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.. Journal of Clinical Investigation. 98(6). 1389–1399. 128 indexed citations
15.
Alkemade, Hans, Gijs J. De Jongh, W.P. Arnold, P.C.M. van de Kerkhof, & Joost Schalkwijk. (1995). Levels of Skin-Derived Antileukoproteinase (SKALP)/Elafin in Serum Correlate with Disease Activity During Treatment of Severe Psoriasis with Cyclosporin A. Journal of Investigative Dermatology. 104(2). 189–193. 35 indexed citations
16.
Alkemade, Hans, et al.. (1994). Demonstration of skin‐derived antileukoproteinase (skalp) and its target enzyme human leukocyte elastase in squamous cell carcinoma. The Journal of Pathology. 174(2). 121–129. 27 indexed citations
17.
Alkemade, Hans, et al.. (1993). Differential expression of SKALP/Elafin in human epidermal tumors.. PubMed. 143(6). 1679–87. 38 indexed citations
18.
Molhuizen, H.O.F., Hans Alkemade, Patrick L.J.M. Zeeuwen, et al.. (1993). SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. Journal of Biological Chemistry. 268(16). 12028–12032. 144 indexed citations
19.
Alkemade, Hans, Peter van de Kerkhof, & Joost Schalkwijk. (1992). Demonstration of Skin-Derived Antileukoproteinase (SKALP) in Urine of Psoriatic Patients. Journal of Investigative Dermatology. 99(1). 3–7. 24 indexed citations
20.
Alkemade, Hans, et al.. (1989). Dithranol Modulates the Leukotriene B4-Induced Intraepidermal Accumulation of Polymorphonuclear Leukocytes. Journal of Investigative Dermatology. 92(6). 806–808. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026